APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 263 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 2,618,300 | $238,527,130 | 33.19% |
| ACUTA CAPITAL PARTNERS, LLC | 297,596 | $27,110,996 | 18.37% |
| Avoro Capital Advisors LLC | 11,111,111 | $1,012,222,212 | 13.73% |
| EcoR1 Capital, LLC | 5,451,647 | $496,645,042 | 12.17% |
| Logos Global Management LP | 625,000 | $56,937,500 | 7.74% |
| Finepoint Capital LP | 241,690 | $22,017,959 | 7.62% |
| Cormorant Asset Management, LP | 1,310,000 | $119,341,000 | 6.68% |
| Boxer Capital, LLC | 1,576,000 | $143,574 | 6.66% |
| Saturn V Capital Management LP | 107,406 | $9,784,687 | 5.43% |
| Ghost Tree Capital, LLC | 180,000 | $16,398,000 | 5.41% |